You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Pharmacol., 05 October 2022

Sec. Drug Metabolism and Transport

Volume 13 - 2022 | https://doi.org/10.3389/fphar.2022.1039267

Corrigendum: Evaluation of herb–drug interaction between Danshen and rivaroxaban in rat and human liver microsomes

    XW

    Xu Wang 1

    JF

    Jingjing Fa 1

    YZ

    Yuanjin Zhang 2

    SH

    Shengbo Huang 2

    JL

    Jie Liu 2

    JG

    Junqing Gao 1

    LX

    Lina Xing 1,3

    ZL

    Zongjun Liu 1,3*

    XW

    Xin Wang 2*

  • 1. Department of Cardiology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China

  • 2. Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, China

  • 3. Putuo Clinical Medical School, Anhui Medical University, Shanghai, China

Article metrics

View details

1

Citations

1,2k

Views

592

Downloads

In the published article, there was an error in affiliation 1. Instead of “Department of Cardiology, Central Hospital of Shanghai Putuo District, Shanghai University of Traditional Chinese Medicine, Shanghai, China”, it should be “Department of Cardiology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

Danshen, rivaroxaban, herb-drug interaction, metabolism, cytochrome P 450 (CYP)

Citation

Wang X, Fa J, Zhang Y, Huang S, Liu J, Gao J, Xing L, Liu Z and Wang X (2022) Corrigendum: Evaluation of herb–drug interaction between Danshen and rivaroxaban in rat and human liver microsomes. Front. Pharmacol. 13:1039267. doi: 10.3389/fphar.2022.1039267

Received

08 September 2022

Accepted

21 September 2022

Published

05 October 2022

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

13 - 2022

Updates

Copyright

*Correspondence: Zongjun Liu, ; Xin Wang,

†These authors have contributed equally to this work

This article was submitted to Drug Metabolism and Transport, a section of the journal Frontiers in Pharmacology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics